Mitophagy protects beta cells from inflammatory damage in diabetes
Preprint posted on June 09, 2020 https://www.biorxiv.org/content/10.1101/2020.06.07.138917v1
Article now published in JCI Insight at http://dx.doi.org/10.1172/jci.insight.141138
Context and Background:
Classically known as the powerhouse of cells, mitochondria are so much more than that. These organelles are important signaling hubs that control and coordinate a variety of cellular functions, including metabolism, response to stress and cell death. Therefore, the maintenance of a healthy mitochondrial network is pivotal for survival and the signals emitted from dysfunctional mitochondria are at the origin of a variety of diseases, including cardiovascular and neurodegenerative diseases and type-1 and type-2 diabetes (TD-1 and TD-2).
Mitophagy, a specialized form of autophagy, mediates the selective removal of damaged mitochondria and preserves the homeostasis of the network. Recently, the endosomal protein Clec16a has been characterized as a new activator of mitophagy in b-cells. GWAS studies have classified Clec16a as a susceptibility gene for type 1 diabetes and SNPs in this locus have been linked to the development of diabetes. Moreover, reduced levels of Clec16a in human islets has been associated with dysfunctional b-cell activity and compromised glucose control. However, whether Clec16a (and mitophagy in general) plays any role in the defense of b-cells from inflammation-derived injury has not been explored yet.
Since the early 1950’s a causal link between inflammation and development of insulin resistance was suspected. Nowadays, it is well established that the chronic activation of pro-inflammatory signals (as the ones mediated by pro-inflammatory cytokines) predisposes to a decreased insulin sensitivity and contributes to the onset of diabetes. It is therefore important to understand the response of b-cells to inflammation and investigate whether special cytoprotective response are in place to withstand the damage.
In this preprint, Sidarala et al. identify Clec16a as an important player in the protection of b-cells from inflammatory damage through the activation of mitophagy.
The authors show that mitochondria of b-cells exposed to pro-inflammatory cytokines accumulate a great deal of oxidative damage, resulting in the loss of mitochondrial membrane potential, decreased oxygen consumption and a reduced ATP/ADP ratio. Given that optimal mitochondrial activity is essential for the response to glucose, healthy b-cells dispose oxidized mitochondria by activating mitophagy, preserving a healthy mitochondrial network (Figure 1, left panel). Activation of inflammation-mediated mitophagy is reversible and can be limited by withdrawal of pro-inflammatory cytokines, by inhibition of free radical generation (NOS2-/-) or by exposure to superoxide scavengers.
Activation of mitophagy is key to preserve b-cell function. Blocking mitophagy by removing the key mitophagy regulator Clec16a (b-Clec16aKO), exacerbates the inflammatory response leading to a progressive reduction in mitochondrial volume, increased mitochondria fragmentation and ultimately enhanced apoptosis (Figure 1, right panel). Consequently, b-cell death affects insulin production resulting in the exaggerated increase in blood glucose levels. The authors suggest that mitophagy is an essential protective strategy that promotes b-cell survival in response to uncontrolled oxidative stress. This conclusion is further supported by the observation that overexpression of Clec16a in human islets protects b-cells from inflammation-induced apoptosis.
Figure 1: Clec16a-mediated mitophagy prevents the onset of diabetes. Left panel: in healthy b-cells oxidized mitochondria are promptly removed by mitophagy. This cellular response is controlled by the master regulator Clec16a and it is marked by the localization of cytosolic Parkin (in blue) to damaged mitochondria. Dysfunctional, fragmented mitochondria are cleared up by proteolytic degradation in the lysosomes. This strategy preserves the integrity of the mitochondrial network and promotes cell viability. Right panel: inhibition of mitophagy increases cell susceptibility to inflammation, resulting in the aberrant accumulation of damaged mitochondria and activation of the apoptotic response. Preventing mitophagy can be propaedeutic to the development of type 1 and type 2 diabetes. Image was generated with the help of Biorender.
This preprint identifies Clec16a as important mediator of b-cell survival following inflammation. By activating mitophagy, Clec16a fine-tunes b-cell susceptibility to inflammatory stress and apoptosis and emerges as a relevant therapeutic target for the treatment of diabetes.
Questions to the authors:
- Immune cells have been shown to be able to transfer mitochondria to sensory neurons via extracellular vesicles. Do you think that a similar thing might happen with b-cells to replenish the pool of healthy mitochondria?
- Clec16a has been linked to the development of other diseases (i.e. multiple sclerosis). Do you think this protein regulates tissue homeostasis via the same mechanism (namely mitophagy) or do you think it is more of a ‘swiss army knife’?
Posted on: 23rd June 2020 , updated on: 25th June 2020Read preprint
Also in the cell biology category:
Pseudo-dynamic analysis of heart tube formation in the mouse reveals strong regional variability and early left-right asymmetry
|Selected by||Yen Tran|
TEMPO: A system to sequentially label and genetically manipulate vertebrate cell lineages
|Selected by||Julia Grzymkowski|
In situ architecture of the ciliary base reveals the stepwise assembly of IFT trains
|Selected by||Nicola Stevenson|
preListscell biology category:in the
The advances in fibroblast biology preList explores the recent discoveries and preprints of the fibroblast world. Get ready to immerse yourself with this list created for fibroblasts aficionados and lovers, and beyond. Here, my goal is to include preprints of fibroblast biology, heterogeneity, fate, extracellular matrix, behavior, topography, single-cell atlases, spatial transcriptomics, and their matrix!
|List by||Osvaldo Contreras|
EMBL Synthetic Morphogenesis: From Gene Circuits to Tissue Architecture (2021)
A list of preprints mentioned at the #EESmorphoG virtual meeting in 2021.
|List by||Alex Eve|
A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020
|List by||Ana Dorrego-Rivas|
Planar Cell Polarity – PCP
This preList contains preprints about the latest findings on Planar Cell Polarity (PCP) in various model organisms at the molecular, cellular and tissue levels.
|List by||Ana Dorrego-Rivas|
BioMalPar XVI: Biology and Pathology of the Malaria Parasite
[under construction] Preprints presented at the (fully virtual) EMBL BioMalPar XVI, 17-18 May 2020 #emblmalaria
|List by||Dey Lab, Samantha Seah|
Recent research from the field of cell polarity is summarized in this list of preprints. It comprises of studies focusing on various forms of cell polarity ranging from epithelial polarity, planar cell polarity to front-to-rear polarity.
|List by||Yamini Ravichandran|
Preprints recently presented at the virtual Allied Genetics Conference, April 22-26, 2020. #TAGC20
|List by||Maiko Kitaoka et al.|
A curated list of preprints related to Gastruloids (in vitro models of early development obtained by 3D aggregation of embryonic cells). Updated until July 2021.
|List by||Paul Gerald L. Sanchez and Stefano Vianello|
ECFG15 – Fungal biology
Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome
|List by||Hiral Shah|
ASCB EMBO Annual Meeting 2019
A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)
|List by||Madhuja Samaddar et al.|
EMBL Seeing is Believing – Imaging the Molecular Processes of Life
Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019
|List by||Dey Lab|
Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.
|List by||Sandra Malmgren Hill|
Lung Disease and Regeneration
This preprint list compiles highlights from the field of lung biology.
|List by||Rob Hynds|
A curated list of preprints related to cellular metabolism at Biorxiv by Pablo Ranea Robles from the Prelights community. Special interest on lipid metabolism, peroxisomes and mitochondria.
|List by||Pablo Ranea Robles|
BSCB/BSDB Annual Meeting 2019
Preprints presented at the BSCB/BSDB Annual Meeting 2019
|List by||Dey Lab|
This list of preprints is focused on work expanding our knowledge on mitochondria in any organism, tissue or cell type, from the normal biology to the pathology.
|List by||Sandra Franco Iborra|
Biophysical Society Annual Meeting 2019
Few of the preprints that were discussed in the recent BPS annual meeting at Baltimore, USA
|List by||Joseph Jose Thottacherry|
ASCB/EMBO Annual Meeting 2018
This list relates to preprints that were discussed at the recent ASCB conference.
|List by||Dey Lab, Amanda Haage|